Evidence map›Paper›PMID 41556112›Full record

ArticleBJPsych open2026

A symptom network approach to schizophrenia in the CATIE study: processing speed as the central cognitive impairment.

Khan Buchwald, Richard J Siegert, Matthieu Vignes, Ajit Narayanan, Margaret Sandham

Abstract read
In one paragraph

Article in BJPsych open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Khan BuchwaldSchool of Sciences, Auckland University of Technologyhttps://ror.org/01zvqw119, Auckland, New Zealand.ORCID https://orcid.org/0000-0002-9623-9723
Richard J SiegertDepartment of Psychology and Neuroscience, Auckland University of Technology, Auckland, New Zealand.
Matthieu VignesSchool of Mathematical and Computational Sciences, Massey University, Palmerston North, New Zealand.
Ajit NarayananEngineering, Computer, and Mathematical Sciences, Auckland University of Technology, Auckland, New Zealand.
Margaret SandhamSchool of Psychology, Massey University, Auckland, New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeople diagnosed with schizophrenia can have functional impairments in multiple domains. Cognitive impairment is central to schizophrenia and has substantial prognostic value compared with other symptoms of schizophrenia. However, no study has previously investigated directed relationships in a complex system of cognitive, sociodemographic, clinical and quality of life (QOL) variables in people diagnosed with schizophrenia.

aimsTo identify the complex relationships of components of cognition with other cognitive components, as well as with clinical and QOL variables.

methodThis study included data from 1450 participants in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study. The present study reconstructed a Bayesian network from this data using cognition, clinical, sociodemographic and QOL variables.

resultsProcessing speed was centrally associated with all other cognitive domains. Cognitive domains were conditionally independent of positive symptoms but moderately associated with negative symptoms (

conclusionsIntervening with respect to processing speed may be the most beneficial way of improving other cognitive functions. More research is needed on directed networks that include social cognition and global levels of functioning.

Indexed as

Bayesian networkcognitionpsychosisSchizophreniasymptom network

Identifiers

PMID41556112
PMCPMC12835699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.